Announced
Synopsis
iMedX, an international leader in revenue cycle management, medical documentation, and health information solutions has successfully completed the acquisition of Prevalent and Axcension. Financial terms were not disclosed. Both Axcension and Prevalent are proven providers of cutting-edge healthcare analytics and revenue cycle management consulting services. "A comprehensive analytics platform will be a vital part of every provider's RCM workflow in the coming years, which is why these acquisitions are so important to us. Having thorough insight into billing operations will be a necessity as we continue to maximize reimbursement for our clients in an everchanging regulatory environment." Christopher Foley, Chairman and CEO of iMedX.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.